Aurobindo Pharma Ltd has received product approval from Health Canada for Citalopram Hydrobromide tablets 20 mg & 40 mg.
Citalopram Hydrobromide tablets 20 mg & 40 mg is the first formulation approval in Canada. The company is already selling Citalopram Hydrobromide tablets in the US market. The company has established a subsidiary in Canada to serve the local market and also filed many dossiers.
Citalopram Hydrobromide tablets are indicated in the treatment of depressive disorders. The API is manufactured at Unit 1 and the formulation facility of the company is already approved by Health Canada.
Citalopram Hydrobromide tablets are a generic equivalent of Forest Laboratories' Celexa and belongs to selective serotonin reuptake inhibitors (SSRIs) class of medication.